Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2682-2689

  Ingvarsson, Sigurdur ^b   Agnarsson, Bjarni A ^b   Sigbjornsdottir, Bjarnveig I ^b   Kononen, Juha ^c   Kallioniemi, Olli P ^c   Barkardottir, Rosa B ^b   Kovatich, Albert J ^a   Schwarting, Roland ^a   Hauck, Walter W ^a   Huebner, Kay ^a   McCue, Peter A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CHROMOSOME 3P; GENE DELETION; GENE FREQUENCY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PROTEINS; TRANSCRIPTION FACTORS;

EID: 0033152189     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ingvarsson, S. Molecular genetics of breast cancer progression. Semin. Cancer Biol., in press, 1999.
2. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, A. P., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, M. L., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Morris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. K., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, S., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science (Washington DC), 266: 66-71, 1994.
3. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkardottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility gene, BRCA2. Nature (Lond.), 378: 789-792, 1995.
4. Gudmundsson, J., Johannesdottir, G., Bergthorsson, J. T., Arason, A., Ingvarsson, S., Egilsson, V., and Barkardottir, R. B. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res., 55; 4830-4832, 1995.
5. Gudmundsson, J., Johannesdottir, G., Arason, A., Arason, A., Ingvarsson, S., Egílsson, V., and Barkardottir, R. B. Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am. J. Hum. Genet., 58: 749-756, 1996.
6. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J. F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tranchant, M., Swaver-Feldhaus, Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
7. Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ogmundsdottir, H. M., and Eyfjord, J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet., 13: 117-119, 1996.
8. Johannesdottir, G., Gudmundsson, G., Bergthorsson, J. T., Arason, A., Agnarsson, B. A., Eiriksdottir, G., Johannsson, O. T., Borg, A., Ingvarsson, S., Easton, D. F., Egilsson, V., and Barkardottir, R. B. High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res. 56: 3663-3665, 1996.
9. Thorlacius, S., Sigurdsson, S., Bjarnadottir, H., Olafsdottir, G., Jonasson, J. G., Tryggvadottir, L., Tulinius, H., and Eyfjord, J. E. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet., 60: 1079-1084, 1997.
10. Bergthorsson, J. T., Johannsdotlir, J., Jonasdottir, A., Eiriksdottir, G., Egilsson, V., Ingvarsson, S., Barkardottir, and Arason, A. Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2. Eur. J. Cancer, 34: 142-147, 1998.
11. Ingvarsson, S., Geirsdottir, E. K., Johannesdottir, G., Sigbjornsdottir, B. I., Eiriksdottir, G., Ragnarsson, G., Agnarsson, B. A., Gudmundsson, J., Jonasson, J. G., Sigurdsson, A., Egilsson, V., and Barkardoltir, R. B. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999de15 mutation. Cancer Res., 58: 4421-4425, 1998.
12. Tirkkonen, M., Johannsson, O., Agnarsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O. P. Distinct somtic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
13. Eiriksdottir, G., Bergthorsson, J. T., Sigurdsson, H., Gudmundsson, J., Skirnisdottir, S., Egilsson, V., Barkardottir, R. B., and Ingvarsson, S. Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: correlation with clinical variables. Int. J. Oncol., 6: 369-375, 1995.
14. Man, S., Ellis, I. O., Sibbering, M., Blarney, R. W., and Brook, J. D. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res., 56: 5484-5489, 1996.
15. Pandis, N., Bardi, G., Mitelman, F., and Heim, S. Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer, 18: 241-245, 1997.
16. Dietrich, C. U., Pandis, N., Teixeira, M. R., Bardi, G., Gerdes, A. M., Andersen, J. A., and Heim, S. Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int. J. Cancer, 60: 49-53, 1995.
17. Petersson, C., Pandis, N., Mertens, F., Adeyinka, A., Ingvar, C., Ringberg, A., Idvall, I., Bondeson, L., Borg, A., Olsson, H., Kristoffersson, U., and Mitelman, F. Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Genes Chromosomes Cancer, 16: 185-188, 1996.
18. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
19. Panagopoulos, I., Pandis, N., Thelin, S., Petersson, C., Mertens, F., Borg, A., Kristoffersson, U., Mitelman, F., and Aman, P. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res., 56: 4871-4875, 1996.
20. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
21. Hayashi, S., Tanimoto, K., Hajiro-Nakanishi, H., Tsuchiya, E., Kurosumi, M., Higashi, Y., Imai, K., Suga, K., and Nakachi, K. Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res., 57: 1981-1985, 1997.
22. Huebner, K., Garrison, P. N., Barnes, L. D., and Croce, C. M. The role of the FRA3B/FHIT locus in cancer. Annu. Rev. Genet., 32: 7-31, 1998.
23. Bergthorsson, J. T., Eiriksdotlir, G., Barkardottir, R. B., Egilsson, V., Arason, A., and Ingvarsson, S. Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3. Hum. Genet., 96: 437-443, 1995.
24. Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulcvicz, V. L-J., and Ashworth, A. Tumongenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet., 17: 423-430, 1997.
25. 25. Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., and Venkitaraman, A. R. Involvement of Brca2 in DNA repair. Mol. Cell, I: 347-357, 1998.
26. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by rad51 in mice lacking Brac2. Nature (Lond.), 386: 804-810, 1997.
27. Hadaczek, P., Siprashvili, Z., Markiewski, M., Domagala, W., Druck, T., McCue, P. A., Pekarsky, Y., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.
28. Kovatich, A., Friedland, D. M., Druck, T., Hadaczek, P., Huebner, K., Comis, R. L., Hauck, W., and McCue, P. A. Human chromosome 3p alterations in neuroendocrine lung tumors. Cancer (Phila.), 83: 1109-1117, 1998.
29. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
30. Kommen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-through put molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
31. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, K., Bennett, L. M., Haugen-Strano, S. J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., lglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
32. Zhang, H., Tombline, G., and Weber, B. L. BRCA1, BRCA2, and DNA damage response: collision or collusion? Cell, 92: 433-436, 1998.
33. Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomilinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., and Scully, R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell, 2: 317-328, 1998.